共 50 条
- [31] Anthracyclines survive targeted therapy - The Ning/He/Dagher et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (12): : 1516 - +
- [32] The continuing challenge of metastatic breast cancer - The Higgins/Wolff article reviewed ONCOLOGY-NEW YORK, 2008, 22 (06): : 623 - +
- [33] The moving target of cancer care costs - The McKoy/Fitzner/Edwards et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 862 - +
- [34] A new era in the management of multiple myeloma - The Ghobrial/Ghobrial/Mitsiades et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 800 - 800
- [35] Erlotinib in pancreatic cancer: A major breakthrough? The Senderowicz/Johnson/Sridhara et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (14): : 1706 - +
- [36] Discussing disease progression and end-of-life decisions - The Baile et al article reviewed ONCOLOGY-NEW YORK, 1999, 13 (07): : 1031 - 1032
- [37] Preventing Prostate Cancer Overdiagnosis From Becoming Overtreatment THE CROSWELL ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (06): : 468 - 478
- [38] Hepatocellular carcinoma: Neoadjuvant therapy reconsidered - The Almhanna/Kalmadi/Pelley et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1122 - +
- [39] Key developments in rectal cancer treatment - The Willet/Duda/Czito et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1075 - +
- [40] Follicular lymphoma: Expanding therapeutic options - The Ganti/Bociek/Bierman et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (02): : 234 - 235